The plasma membrane has gained increasing attention as a possible target of antitumor drugs. It has been reported that they act as growth factor antagonists, growth factor receptor blockers, interfere with mitogenic signal transduction or exert direct cytotoxic effects. Chlor ambucil (4-[p-(bis[2-chloroethyl]amino)phenyl]butyric acid) is an alkylating agent widely used in the treatment of chronic lymphocytic leukaemia. Contradictory reports have been published concerning its interaction with cell membranes. Whereas a decrease in the fluidity of Ehrlich ascite tumor cells has been adduced, no evidences were found that chlorambucil changes membrane lipid fluidity and alkylating agents had effects in these systems even at highly toxic concentrations. Our results showed that chlorambucil at a dose equivalent to its therapeutical concentration in the plasma (3.6 (.im ) caused the human erythrocyte membrane to develop cup-shaped forms (stomatocytes). Accordingly to the bilayer couple hypothesis, this means that the drug is inserted into the inner monolayer of the erythrocyte membrane, a conclusion supported by X-ray diffraction performed on multilayers of dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylethanolamine (DMPE), representative of phospholipid classes located in the outer and inner monolayers of the erythrocyte membrane, respectively. It is concluded that the cytotoxic effect of chlorambucil might be due to alter ation of the structure and therefore of the physiological properties of cell membranes such as fluidity, permeability, receptor and channel functions.
Introduction
Alkylating agents have been used for more than 30 years as cytotoxic drugs to treat many malig nancies (Shulman, 1993) . These compounds re place the hydrogen of a reacting chemical by an alkyl group. It is generally believed that DN A alkylation is responsible for the antitumor effect of alkylating drugs (Povirk and Shuker, 1994) . A l though there is good correlation between DNA cross-linking and growth inhibition, clear-cut evi dence that this is the only essential event leading to blockade of cell proliferation by bifunctional al kylating agents is still lacking (Grunicke et al., Abbreviations: DMPC, dimyristoylphosphatidylcholine; DMPE, dimyristoylphosphatidylethanolamine; LUV, large unilamellar vesicles; DPH, l,6-diphenyl-l,3,5-hexatriene; Laurdan, 6-dodecanoyl-2-dimethylaminonaphthalene; r, fluorescence anisotropy; GP, general polariza tion; SEM, scanning electron microscopy. 1985a). The plasma membrane as a possible target of antitumor drugs has gained increasing attention (Luxo et al., 1996; Speelmans et al., 1996; Marutaka et al., 1994) , where they act as growth factor antagonists, growth factor receptor blockers, in terfere with mitogenic signal transduction or exert direct cytotoxic effects (Grunicke and Hoffmann, 1992) . Furthermore, drugs which are considered to exert their antiproliferative effect by interacting with DNA cause structural and functional mem brane alterations which may be essential for growth inhibition by these agents (Grunicke et al., 1985b) . However, the detailed mechanism by which alkylating drugs inhibit cell division is still unclear. phenyl]butyric acid, or leukeran), is a bi functional nitrogen mustard (Fig. 1) . It is an alkyl ating agent used in the treatment of chronic lymphocytic leukaemia, the most prevalent form of this disease in Western countries (Löf et al., 1997). Fluorescence spectroscopy has shown that it decreased the fluidity of Ehrlich ascite tumor cell membranes, an effect due to direct interaction with the plasma membrane, expressed at all con centrations of the drug which inhibited cell prolif eration (Grunicke et al., 1983) . Additional studies yielded no evidence for a change in membrane lipid fluidity, and it was concluded that bifunc tional alkylating agents caused the observed ef fects by forming membrane protein cross-links (Grunicke et al., 1985b) . On the other hand, spinlabel methods showed that alkylating agents had no effect on the fluidity of phospholipid mem branes or of Ehrlich ascites tumour cells mem branes even at highly toxic concentrations (Ankel et al., 1986) . The controversy surrounding the in teraction of chlorambucil with cell membranes en couraged us to undertake a study concerning this subject. This paper describes the interaction of chlorambucil with the human erythrocyte mem brane and models constituted by phospholipid multilayers and large unilamellar vesicles (LUV). These systems have been used in our laboratories to determine the interaction and perturbing effects on membranes by other anticancer drugs such as tamoxifen and adriamycin . The interactions of chlor ambucil with human erythrocytes were examined by scanning electron microscopy (SEM) to detect shape changes induced by the drug. The multilay ers consisted of the phospholipids dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylethanolamine (DMPE), representative of phospholipid classes located in the outer and inner monolayers of the human erythrocyte membrane, respectively (Devaux and Zachowsky, 1994) . Given the amphipathic character of chlorambucil and of both phospholipids their interactions were assayed in hydrophobic and aqueous media in a range of concentrations. Chlorambucil perturba tion of the DM PC and DM PE multilayer struc tures was determined by X-ray diffraction (Suwal sky, 1988) . The effect of the drug on the physical properties of DM PC LUV was studied evaluating
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DPH steady state fluorescence anisotropy and laurdan fluorescence spectral shifts.
Materials and Methods

Scanning electron microscope (SEM) studies on human erythrocytes
Blood samples taken from clinically healthy male adult donors by puncture of the ear lobe dis infected with 70% ethanol were incubated with chlorambucil. Two drops of blood were collected in a plastic tube containing 1 ml of saline (0.9% NaCl) at 5 °C. This solution was used to prepare the following samples: a) control, by mixing 0.1 ml with 0.9 ml of saline, and b) 3.6 | im chlorambucil by mixing 0.1 ml with 0.9 ml of chlorambucil in adequate concentration. This concentration is that present in plasma when the drug is administered to patients (American Hospital Formulary Service Drug Information 95, 1995) .The samples were in cubated at 37 °C for 1 h and then fixed with glutaraldehyde adding one drop of each sample to a tube containing 1 ml of 2.5% glutaraldehyde in sa line, reaching a final fixation concentration of about 2.4%. After resting overnight at 5 °C the fixed samples were directly placed on Al stubs, air dried at 37 °C for half to one h and gold coated for 3 min at 10-i Torr in a sputter device (Edwards S150, Sussex, England). Resulting specimens were examined in an Etec Autoscan SEM (Etec Corp., Hayward, CA, USA).
X-ray diffraction analysis of phospholipid multilayers
Synthetic DMPC (lot 80H-8371 A grade MW 677.9), DMPE (lot 13H-83681 A grade MW 635.9) and chlorambucil (lot 44H2605, M W 304.2) from Sigma (St. Louis, MO, USA) were used without further purification. About 5 mg of each phospho lipid were mixed with the corresponding weight of chlorambucil in order to attain DMPQchlorambucil and DMPE:chlorambucil powder mixtures in the molar ratios of 10:1, 5:1 and 1:1. Each mixture was dissolved in chloroform:methanol 3:1 v/v and left to dry. The recrystallized samples were placed in special glass capillaries 0.7 mm diameter (Glas Technik & Konstruktion, Berlin, Germany). They were diffracted in Debye-Scherrer cameras of 114.6 mm diameter (Philips, The Netherlands) and flat-plate cameras built by us with 0.25 mm diame ter glass collimators provided with rotating de vices. The same procedure was followed with sam ples of each phospholipid and chlorambucil. The aqueous specimens were prepared in 1 mm diame ter glass capillaries mixing each phospholipid and chlorambucil in the proportions described above. Each capillary was then filled with about 100 [d of distilled water. These specimens were X-ray dif fracted 2 days after preparation in flat-plate cam eras. Specimen-to-film distances were 8 and 14 cm, standardized by sprinkling calcite powder on the capillary surface. Ni-filtered CuKa radiation from a Philips PW1140 X-ray generator (The Nether lands) was used. The relative reflection intensities on films were measured by peak-integration in Joyce-Loebl M KIIICS (England) and Bio Rad GS-700 (Hercules, CA, USA) microdensitometers using the Bio-Rad Molecular Analyst/PC image software. The experiments in water were per formed at 17 ± 2 °C, which is below the main tran sition temperature of both DM PC and DMPE. Higher temperatures would have induced transi tions to more fluid phases making it harder to de tect the structural changes produced by chloram bucil.
Fluorescence measurements on large unilamellar vesicles (LUV)
DMPC LUV suspended in water were prepared by extrusion of frozen and thawed multilamellar liposome suspension (final lipid concentration 0.5 m M ) through two stacked polycarbonate filters of 400 nm pore size (Nucleopore, Corning Costar Corp., Cambridge, MA, USA) under nitrogen pressure at 10 °C above the lipid transition tem perature. DPH and laurdan were incorporated into LUV by addition of small aliquots of concen trated solutions of the probe in tetrahydrofurane and ethanol respectively to LUV suspensions and gently shaken for about 30 min. Fluorescence spectra and anisotropy measurements were respectively performed in a Spex Fluorolog (Spex Industries Inc., Edison, NJ, USA) and in a phase shift and modulation Greg-200 steady-state and time-resolved spectrofluorometer (I. S. S. Inc., Champaign, IL, USA), both interfaced to comput ers. Software from I. S. S. was used for data collec tion and analysis. Measurements of LU V suspen sions were made at 18 °C in 10 mm path-length square quartz cuvettes. Sample temperature was controlled by an external bath circulator (Cole Parmer, Chicago, IL, USA) and measured prior and after each measurement using a digital ther mometer (Omega Engineering. Inc., Stanford, CT, USA). Anisotropy measurements were made in the "L" configuration using prism polarizers (Gian Thompson, I. S. S.) in both exciting and emitting beams. The emission was measured across a high pass filter (Schott WG-420, Mainz, Germany) with negligible fluorescence. Laurdan fluorescence spectral shifts were quantified through the Gene ral Polarization (GP) concept which was evaluated by GP=(Ib-Ir)/(Ib+Ir), where lb and Ir are the in tensities at the blue and red edges of the emission spectrum, respectively. These intensities have been measured at the emission wavelengths of 440 and 490 nm, which correspond to the emission maxima of laurdan in the gel and liquid crystalline phases, respectively (Parasassi and Gratton, 1995) . Chlor ambucil was incorporated in LUV suspensions by addition of small aliquots of a concentrated etha nol solution and incubated at 40 °C for ca. 15 min. Samples with probes, including ethanol, but with out chlorambucil showed no variation in the mea sured parameters during periods longer than those employed in the experiments. Blank subtraction was performed in all measurements using unla belled samples without probes.
Results
Scanning electron microscopy (SEM) studies on human erythrocytes
SEM of red cells incubated with 3.6 | i m revealed abnormalities in their shapes. In contrast to the normal discoid erythrocyte profile (Fig. 2a) a great number of chlorambucil treated cells underwent stomatocytic shape changes, i.e., evagination of one surface and invagination of the opposite face (Fig. 2b) . The assayed concentration of chloram bucil is equivalent to that found in plasma after its therapeutical administration.
X-ray diffraction analysis of phospholipid multilayers
The molecular interactions of chlorambucil with multilayers of the phospholipids DMPC and DM PE were investigated in hydrophobic and aqueous media. Fig. 3A shows a comparison of the diffraction patterns of DMPC and chlorambucil and of their 10:1, 5:1 and 1:1 molar mixtures after interacting and recrystallizing from CHC13 : CH 3O H 3:1 (v/v). Results indicated that the X-ray pattern of DMPC was affected by the drug: in the 10:1 molar ratio, chlorambucil perturbed the high angle region of DM PC to a large extent and its intense reflections of 4.30 A and 4.19 A were re placed by a strong band of 4.2 A. Increasing the drug concentration decreased DMPC reflection intensities, although the phospholipid bilayer width remained practically constant at about 55 A. The main reflections of chlorambucil were present in the 1:1 and 5:1 molar mixtures. These results implied that only a limited amount of chlorambu cil penetrated the phospholipid bilayer perturbing mainly its acyl chain packing arrangement. Fig. 3B shows the results obtained after DMPC, chloram bucil and their molar mixtures in the same ratios as above were immersed in distilled water. DMPC bilayer width increased from 55 A when dry to 64.0 A. Its reflections were reduced to only the first three orders of the bilayer width and a rela tively intense reflection of 4.2 A. The latter arose from the stiff and fully extended acyl chains orga nized with rotational disorder in an hexagonal lat tice. Increasing proportions of chlorambucil in the mixtures produced the following effects: a) a grad ual decrease of DM PC reflection intensities in both the low and high angle regions, which were of the order of 64% at the highest concentrations of the drug; b) an expansion of the bilayer width up to 70.4 A, attained in the 5:1 molar ratio, which decreased to 66.6 A in the 1:1 molar mixture, and c) the presence of the drug reflections in the 1:1 and 5:1 samples. These results indicated that chlor ambucil, despite its low solubility in water, in teracted with DMPC perturbing its bilayer struc ture.
Results of the interaction of chlorambucil with DM PE in the hydrophobic medium are shown in Fig. 3C . As reported elsewhere (Suwalsky et al., 1991) , DMPE presents two polymorphic forms. One form (Lc]) has the acyl chains extended and parallel to the bilayer normal, and its bilayer width is about 52 A. In the other form (Lc2) the acyl chains are tilted by about 302 and the bilayer width is nearly 44 A. Chlorambucil induced the following effects in DMPE: a) an Lct to Lc2 phase transition; and b) a decrease of its reflection inten sities. However, the bilayer width of the DMPE L c2 form remained practically constant at 45.0 A. On the other hand, reflections from the drug were observed only in the 1:1 molar mixture. Fig. 3D illustrates the interaction of chlorambucil with DM PE in water; the drug did not evoke a phase transition in DMPE, which remained throughout in the Lct form. However, it induced a gradual reduction of the lipid reflection intensities as its molar ratio increased, reaching an average of an 82% reduction in the high angle reflection inten sities. The strongest reflections of chlorambucil were observed only in its 1:1 molar mixture with DMPE. These results implied an extensive interac tion of the drug with DMPE, somewhat higher than that observed with DMPC. This was rather surprising in view of the fact that DM PE mole cules pack closer and tighter than those of DMPC, its structure being more difficult to penetrate and disturb (Suwalsky, 1988) .
Fluorescence measurements on large unilamellar vesicles (LUV)
The structural effects of chlorambucil on DMPC LUV were determined at the acyl chain deep hy drophobic and hydrophilic/hydrophobic interface regions of the phospholipid bilayer, by evaluation of DPH steady state fluorescence anisotropy (r) and laurdan general polarization (GP). As shown in Table I , increasing concentrations of chloram bucil up to 1 mM decreased r and GP values to the order of 16% and 30%, respectively. The DPH steady state anisotropy is primarily related to the rotational motion restriction due to the hydrocar- bon chain packing order. Therefore, the decrease of this parameter can be explained by a structural perturbation of the bilayer hydrophobic region due to the incorporation of chlorambucil. On the other hand, the effect of laurdan GP indicated that the dynamics of the dipolar relaxation and/or the water penetration into the polar head group re gion was increased by the incorporation of the drug. These results tend to agree with those ob served in the X-ray diffraction experiments per formed on DMPC multilayers in an aqueous me dium.
Discussion
There is general consensus on the role of cell membranes in carcinogenesis (Galeotti et al., 1988) . Thus, the plasma membrane has gained increasing attention as a possible target of antitu mor drugs (Luxo et al., 1996; Speelmans et al., 1996; Marutaka et al., 1994) . It has been reported that they act as growth factor antagonists, growth factor receptor blockers, interfere with mitogenic signal transduction or exert direct cytotoxic effects (Grunicke and Hoffmann, 1992) . Moreover, drugs that interact with DN A cause structural and func tional membrane alterations which may be essen tial for growth inhibition by these agents (Grun icke et al., 1985b) . Chlorambucil is an alkylating agent widely used in the treatment of chronic lym phocytic leukaemia. Contradictory reports have been published concerning its interaction with cell membranes. Thus, Grunicke et al. (1983) reported that it decreased fluidity of Ehrlich ascite tumor cells; after additional studies, they informed that no evidence was found for a change in membrane lipid fluidity (Grunicke et al., 1985b) . It has also been stated that alkylating agents had no effects in these systems even at highly toxic concentrations (Ankel et al., 1986) . Our results indicate that chlorambucil interacts with the erythrocyte mem brane and phospholipid bilayers of molecular models. In fact, human erythrocytes incubated with a dose of chlorambucil equivalent to its thera peutical concentration in plasma, developed cup shaped forms (stomatocytes). According to the bi layer couple hypothesis (Sheetz and Singer, 1974) , the shape changes induced by foreign molecules in erythrocytes are due to a differential expansion of the two monolayers. Thus, stomatocytes are pro duced when the added compound locates into the inner leaflet whereas spiculated-shaped equinocytes are observed when it inserts into the outer moiety (Lange et al., 1982) . It can therefore be concluded that chlorambucil preferentially in serted into the inner monolayer of the erythrocyte membrane. This conclusion is supported by the re sults obtained with multilayers of DMPC and DMPE. X-ray diffraction analysis indicated that the drug interacted w'ith both lipids. Chemically they only differ in their terminal amino groups, these being + NH3 in DMPE and + N(CH3)3 in DMPC. Moreover, both molecular conformations are very similar in their dry crystalline phases: their acyl chains are mostly parallel and extended with the polar groups lying perpendicularly to them. However, DM PE molecules pack tighter than those of DMPC. This effect, due to the DM PE smaller polar group and higher effective charge, makes for a very stable multilayer arrange ment which is not significantly perturbed by water. On the other hand, the gradual hydration of DM PC bilayers leads to water filling the highly polar interbilayer spaces (Suwalsky, 1988) . Conse quently, there is a) an increase in its bilayer width from 55.0 A when dry up to 64.0 A when fully hydrated, and b) a decrease in the number of re flections due to the resulting increase in its fluidity. These conditions facilitate the incorporation of chlorambucil into DM PC bilayers, its penetration into the acyl chain and polar regions and the ensu ing molecular perturbation of the phospholipid bi layer structure. Thus, apparently it is amazing that chlorambucil is able to induce a somewhat higher perturbation in the tighter DMPE structure than in the more open structure of DMPC. Although this effect is rather uncommon, it has been ob served with other molecules . On the other hand, the re sults obtained by fluorescence spectroscopy in DMPC LU V tend to agree with those revealed by X-ray diffraction in DM PC multilayers. In conclu sion, our results confirm that chlorambucil inserts into the inner monolayer of the erythrocyte mem brane. Although it cannot be ruled out its interac tion with proteins, our results unambigously showed that chlorambucil interacted with lipid bi layers. Therefore, cell membrane structure and physiological properties such as fluidity, perme ability, receptor and channel functions may be af fected. Such interactivity of chlorambucil with the cell membrane might explain its cytotoxic effect.
